



BeiGene | John V. Oyler - BeiGene

















































































Patients

Pipeline
Clinical Trials


Media

Press Releases
Email Alerts


Contact
 










中文English 
















中文English 







Company

About Us
Our Vision
Management Team

Executive Management
Research
Development
Process Development & Manufacturing
Commercial & Operations


Board of Directors
Scientific Advisory Board
Contact


Our Science

Cancer Biology Platform
Molecularly Targeted Agents
Immuno-oncology Therapies
Combination Solutions


Pipeline

Clinical Candidates

Overview
BGB-3111
BGB-A317
BGB-290
BGB-283


Preclinical Candidates


Business Development

Overview


Investors

Investors Overview
Stock Information

Stock Quote
Stock Chart
Historical Price Lookup
Investment Calculator


Financial Information

SEC Filings
Annual Reports


News & Events

Press Releases
Events Calendar


Corporate Governance

Documents & Charters


Investor Services

Information Request
Email Alerts
IR Contact


Investor FAQ


Careers

Our Culture
Job Opportunities
Campus Recruiting


Patients

Pipeline
Clinical Trials


Media

Press Releases
Email Alerts


Contact

 







 



 

John V. Oyler
Founder & CEO 



Has served as CEO and Director since founding BeiGene in 2010
Founder & CEO of BioDuro, 700-person integrated research CRO in Beijing, sold to Pharmaceutical Product Development Inc. with attractive returns (2005-2009)
CEO of Galenea, Boston biotech started from MIT with funding from Otsuka, (2002-2004)
Founder, President of Telephia, sold to Nielsen (1997-2002)
Co-CEO of Genta (GNTA), publicly-traded oncology company that grew in late ’90s to $1.7 billion in revenues (1997-1998)
Began career at McKinsey & Company
MBA from Stanford University
B.S. from Massachusetts Institute of Technology

 
 
 
 



Company 
CompanyAbout Us
Our Vision
Management Team

Executive Management
Research
Development
Process Development & Manufacturing
Commercial & Operations


Board of Directors
Scientific Advisory Board
Contact
 

 
 
 





























Oyler, John - PITTSBURGH, PA - Company Information









 



























Products
Resources
My Account












Talk to a D&B Advisor 
1-800-280-0780 




Business Directory



PA



PITTSBURGH



Engineering Services



Engineering Services



                            Oyler, John
                                    



 





















O 


Oyler, John
CLAIM THIS BUSINESS



92 YOUNGWOOD RD PITTSBURGH, PA 15228
Get Directions



(412) 343-1652
www.mwn.com





Business Info



 Founded 1991
 Incorporated 
 Annual Revenue $61,000.00
 Employee Count 1
 Industries Engineering Services
 Contacts John Oyler







Contact Business







Your Email Address

Subject:


Message


Send Message





Company Summary


Oyler, John was founded in 1991. Oyler, John specializes in Engineering Services. 









VERIFIED Status:
UNVERIFIED



Address:
UNVERIFIED





LAST VERIFIED:

                                    --
                                



Phone:

                                    UNVERIFIED
                                





Payment Method:
UNVERIFIED


view full report





Similar Businesses Nearby


                                        Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Competitive Landscape


                                        Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Payments Accepted

NO DATA



Hours



                                        Sunday 

                                        

                                                                                            --
                                            
                                        



                                        Monday 

                                        

                                                                                            --
                                            
                                        



                                        Tuesday 

                                        

                                                                                            --
                                            
                                        



                                        Wednesday 

                                        

                                                                                            --
                                            
                                        



                                        Thursday 

                                        

                                                                                            --
                                            
                                        



                                        Friday 

                                        

                                                                                            --
                                            
                                        



                                        Saturday 

                                        

                                                                                            --
                                            
                                        







O

VIEW ADDITIONAL DATA                        
Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it. 







Credibility Review





Google





Facebook.com





Yellowbook.com





Bing.com





Yellowpages.com





MerchantCircle





Tele Atlas (TomTom)





Twitter.com





AOL





MapQuest





Yahoo Local





Apple/Siri





Groupon





Hotfrog.com





Comcast.net Search





ReachLocal





Admedia





Dealsplus





Shoptopia.com





Alteryx





Dogtime Media





KSL.com





Sirtune





AmericanTowns.com





Driverside





Kudzu.com





SpecialsAgent.com





Answers.com





eGood





LawInfo.com





spotlikes.com





anywho.com





eGumball





Likeness.com





Spotzot





eServiceLog





MapMyRun





TechnoCom





apartmentguide.com





ezlocal.com





EZToUse.com





Teleroute





AroundMe.com





metropolist.com





Therapists.com





Atlanta NewHomes





FindLaw.com





Time Out New York





Avantar





FindTheBest.com





mojopages.com





B2B Yellowpages





Fivestar Software





MyCityWay.com





TripAdvisor





bckyrd.com





GiftCards.com





MyCoupons.com





beachcalifornia.com





GoLocal247.com





mymove.com





UpMeSocial.com





Belo





GoodInfo





News-Gazette





Nokia





usdirectory.com





Cars.com





Nomao





Centzy.com





hibu





Openlist.com





ChaCha Search





Homeplate.com





OwnLocal.com





VisiKard





challama.com





Homestore





patch.com





Voltari





CityBot





Pelopidas





Vouchd





ClassifiedAds





Hostway





PlaceIQ





WalkScore.com





CloudMade





Hoodoyou





PlanetDiscover.com





WeddingWire.com





PowerProfiles





Where Inc.





Contractors.com





iGoLocal.com





Radiate Media





Wikiocity





CouponMap





Indeed.com





Wimgo.com





CrowdSpot





Innova Electronics





Intellistrand





realtor.com





DataSphere





InTheMO.com





Reply.com





Yellowbot.com





JiWire





Rocket Fuel





YellowPageCity.com





DMV.org





Justclicklocal.com





Dirxion





Keen.com





Zidster.com












Photos














































Business Credit Report
Receive a one-time comprehensive credit report on this company.
get full credit report


Facebook








Twitter








Yelp






































Call 1.800.280.0780 to speak with a D&B Advisor Today!







Customer Resources
Products
Education Center
Business Articles & Insights
Glossary
Contact Us
Customer Support
Communication Preferences
Search for D&B D-U-N-S




Our Company
About Us
Company History
Business Credit History
Careers
Press Releases
News
Success Stories
Hoovers




Our Network
Partners
Affiliates
Blog
Access to Capital
Entrepreneurial Initiative
D&B International
SupplierEdge




Site Links
Business Directory
Site Map
PIPEDA
Privacy Policy
Website Terms of Service
Product License Agreement







© Dun & Bradstreet, Inc. 2017. All rights reserved.

























 













 













 




John Oyler, Beigene Ltd: Profile & Biography - Bloomberg


































































  

























Feedback





John Oyler

Chairman/CEO/Founder,
Beigene Ltd






Career History




Chairman/CEO/Founder
Beigene Ltd, 2010-PRESENT


President/Founder
Telephia, FORMER


President/CEO
Bioduro LLC, FORMER


Chief Executive Officer
Galenea Corporation, FORMER


Show More









Website:
www.beigene.com






Corporate Information
Address:

No 30, Science Park Road
Zhong-Guan-Cun Life Science Pa
Changping, 102206
China


Phone:
86-10-5895-8000


Fax:
86-10-5895-8080


Web url:
www.beigene.com











From The Web












Personal Information



Education




Master's Degree, Business Administration


Massachusetts Institute of Technology
Bachelor's Degree, Science








Memberships



Board Memberships




Beigene Ltd


Chairman, 2010-PRESENT









Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data




































	SSOE - Oyler, John F

























































































































Undergraduate

Undergraduate Admissions
First Year Program
Transfer Students



Graduate

Graduate Admissions
International Graduate Admissions
Online Graduate Programs



Information

First Year Program
Newly Admitted Students
Choosing A Major
Prospective Student Tours






Departments

Bioengineering
Chemical & Petroleum
Civil & Environmental
Electrical & Computer
Industrial
Mechanical & Materials
Sichuan University Pittsburgh Institute



Programs

Bioengineering
Chemical Engineering
Civil Engineering
Computer Engineering
Electrical Engineering
Engineering Science
Environmental Engineering
Industrial Engineering
Innovation, Product Design and Entrepreneurship
Materials Science and Engineering
Mechanical Engineering
Mining Engineering
Nuclear Engineering
Petroleum Engineering
Sustainable Engineering



Faculty

Awards
Faculty Openings
Faculty Directory






Research

SSOE Research
Corporate Relations
Scientific Journal Editing Roles of SSOE Faculty
Making Research Work
Open Positions for Post-Docs and Faculty
Undergraduate Summer Research Abstracts



Centers, Institutes, & Labs

All Centers, Institutes, and Labs
Centers List
Labs List
Institutes List






Student Resources

Approved Electives
Career Services
Course Listings
Minors and Certificates
Student Organizations
Undergrad Research Opportunities



External Resources

Undergraduate Bulletin
Graduate Bulletin
Library Resources
Pitt Prep Program
Sichuan University Pittsburgh Institute



Student Programs

First Year Program
Prospective Students
International
Co-Op
Diversity
Undergraduate Diversity
Pre-College Diversity
Undergraduate Summer Research Abstracts













Alumni

Office of Development and Alumni Affairs



Corporate

Corporate Relations



Giving

Make A Gift






Resources

Academic Integrity Guidelines
Office of Development & Alumni Relations
Office of Diversity
Staff Listing
Student Code of Conduct
Technology Group



Office of the Dean

Office of the U.S. Steel Dean of Engineering
Annual Report
Award Listing



Swanson School

Social
News
Events
Photos
Enrollment Data
Visit Us
Open Positions














                    Oyler, John F
                


                    Civil & Environmental Engr
                
































Oyler, John F

Faculty
Adjunct Associate Professor
O: 412-624-9871
blyre1@cvgg.rqh



download vcard














Education & Training




PhD in Civil Engineering, Carnegie Mellon, 1972MS in Civil Engineering, Carnegie Mellon, 1961BS in Civil Engineering, Penn State University, 1953






Awards & Honors




(2011) Swanson School of Engineering Adjunct Professor of the year.(2000) American Society of Civil Engineers (Pittsburgh Section) - Professor of the Year Award.(1982) American Society of Civil Engineers (Pittsburgh Section) - Civil Engineer of the Year  Award.(1972) James F. Lincoln Arc Welding Foundation  Award.(1971) American Institute of Steel Construction - Design in Steel Award.Named to the Swanson School of Engineering Professors Honor Roll five times.






Publications




Oyler, J.F., 1980, "The Handling of Unfired Iron Ore Pellets."Oyler, J.F., and Lohmeyer, H.F., 1978, "The Use of High-Alumina Refractories in A Combustion Chamber."Oyler, J.F., 1972, "Vibration and Buckling of Anisotropic Shallow Shells."Oyler, J.F., and Dasynich, T.S., "Material Handling in Modern Ore Pelletizing Plants."






Patents




Oyler, J.F., "Spillage Chute for Traveling Grate Machine," U.S. No. 3358981.Oyler, J.F., "Circular Traveling Grate for Process Requiring Discrete Zones," U.S. No. 4408987.Oyler, J.F., "Circular Solvent Extractor," U.S. Patent 4683029.























































Access to this page has been denied.














Please verify you are a human





            Please click "I am not a robot" to continue
          



            Access to this page has been denied because we believe you are using automation tools to browse the website.
          

            This may happen as a result of the following:
          


              Javascript is disabled or blocked by an extension (ad blockers for example)
            

              Your browser does not support cookies
            


            Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
          

            Reference ID: #b4a47140-70a5-11e7-bf8b-e34613ea1806
          





            Powered by
            PerimeterX
            , Inc.
          














Access to this page has been denied.














Please verify you are a human





            Please click "I am not a robot" to continue
          



            Access to this page has been denied because we believe you are using automation tools to browse the website.
          

            This may happen as a result of the following:
          


              Javascript is disabled or blocked by an extension (ad blockers for example)
            

              Your browser does not support cookies
            


            Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
          

            Reference ID: #b4db5fc0-70a5-11e7-88c9-03deea60e7fe
          





            Powered by
            PerimeterX
            , Inc.
          














Access to this page has been denied.














Please verify you are a human





            Please click "I am not a robot" to continue
          



            Access to this page has been denied because we believe you are using automation tools to browse the website.
          

            This may happen as a result of the following:
          


              Javascript is disabled or blocked by an extension (ad blockers for example)
            

              Your browser does not support cookies
            


            Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
          

            Reference ID: #b510eeb0-70a5-11e7-9732-894968b4d291
          





            Powered by
            PerimeterX
            , Inc.
          











BeiGene Ltd (BGNE.O)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















BeiGene Ltd (BGNE.O)










Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				BGNE.O on Nasdaq


				77.29USD
21 Jul 2017





				    Change	(% chg)


		    
						    --


					            (--)
					        






Prev Close

$77.29


Open

--




Day's High

--


Day's Low

--




Volume

--


Avg. Vol

155,748




52-wk High

$79.25


52-wk Low

$24.53











					Summary





Name
Age
Since
Current Position




							John Oyler

48
2010

                                Chairman of the Board, Chief Executive Officer, Founder




							Howard Liang

52
2015

                                Chief Financial Officer and Chief Strategy Officer




							Wendy Yan

50
2014

                                Senior Vice President, Head of Regulatory Affairs




							Jason Yang

51
2014

                                Senior Vice President, Head of Clinical Development




							Timothy Chen

59
2016

                                Director




							Donald Glazer

71
2013

                                Director




							Michael Goller

40
2015

                                Director




							Ranjeev Krishana

41
2014

                                Director




							Xiaodong Wang

52
2016

                                Director




							Qingqing Yi

43
2014

                                Director



» Insider Trading





					Biographies





Name
Description




							John Oyler


					
							Mr. John V. Oyler is Chairman of the Board, Chief Executive Officer, Founder of the company. since 2010. From 2005 to 2009, Mr. Oyler served as President and Chief Executive Officer of BioDuro, LLC, a drug discovery outsourcing company, which was acquired by Pharmaceutical Product Development Inc. in 2010. From 2002 to 2004, Mr. Oyler served as Chief Executive Officer of Galenea Corp., a biopharmaceutical company dedicated to the discovery of novel therapies for central nervous system diseases, which initially were developed at Massachusetts Institute of Technology. From 1997 to 2002, Mr. Oyler was a Founder and the President of Telephia, Inc. which was sold to The Nielsen Company in 2007. From 1997 to 1998, Mr. Oyler served as Co-Chief Executive Officer of Genta Incorporated (NASDAQ: GNTA), an oncology-focused biopharmaceutical company. Mr. Oyler began his career as a management consultant at McKinsey & Company. Mr. Oyler received his B.S. from Massachusetts Institute of Technology and MBA from Stanford University. Mr. Oyler's qualifications to sit on our board of directors include his extensive leadership, executive, managerial, business and pharmaceutical and biotechnology company experience, along with his years of industry experience in the development and commercialization of pharmaceutical products.




							Howard Liang


					
							Mr. Howard Liang, Ph.D. is Chief Financial Officer and Chief Strategy Officer of the company. Since July 2015 as our Chief Financial Officer and Chief Strategy Officer. Dr. Liang has more than 20 years of combined experience on Wall Street as an analyst covering the biotechnology and pharmaceutical sectors and as a scientist in the biopharmaceutical industry. Prior to joining us, from 2005 to 2015, Dr. Liang was at Leerink Partners LLC, a leading investment bank specializing in the healthcare industry, where he served as a Managing Director and Head of Biotechnology Equity Research. Dr. Liang served as a Senior Biotechnology Analyst at two full-service investment banks: A.G. Edwards Inc., from 2004 to 2005, and JMP Securities, from 2003 to 2004. From 2000 to 2003, Dr. Liang served as an Associate Analyst at Prudential Securities, where he covered major and specialty pharmaceuticals. Before joining Wall Street, from 1992 to 2000, Dr. Liang was with Abbott Laboratories, where he was a Senior Scientist and a member of one of the pharmaceutical industry's leading structure-based discovery teams. During his career as a scientist, Dr. Liang authored a review and 13 papers including six in Nature, Science, and Proceedings of the National Academy of Sciences. Dr. Liang received his B.S. in Chemistry from Peking University and both his MBA and Ph.D. in Biochemistry and Molecular Biology from the University of Chicago.




							Wendy Yan


					
							Ms. Wendy Yan is Senior Vice President, Head of Regulatory Affairs of the company. since August 2014. Prior to joining us, Ms. Yan served in various positions, including Director, Head of Regulatory Affairs for China, and Global Regulatory Strategist, at Bayer HealthCare AG from 2008 to 2014. Prior to that, Ms. Yan served at GlaxoSmithKline Pharmaceutical China as both a director and Head of Regulatory Affairs. Ms. Yan also served as a Senior Regulatory Affair Manager at AstraZeneca plc. previously. Ms. Yan received her M.B.A. from Staffordshire University. She began her career at the Beijing Drug Control Institute and is a licensed pharmacist, having received her Bachelor of Medicine from Beijing Traditional Medicine University.




							Jason Yang


					
							Mr. Jason Yang, M.D., Ph.D. is Senior Vice President, Head of Clinical Development of the company. since July 2014. Prior to joining us, Dr. Yang served as an Oncology Medical Director in Clinical Development and other roles at Covance Inc. from 2011 to 2014. Prior to his time at Covance, Dr. Yang served as a Senior Principal Scientist in cancer biomarker at Pfizer, Inc. for seven years since 2004, and as a research scientist in cancer genomics at Tularik Inc. (acquired by Amgen Inc. in 2004) for six years since 1998. Dr. Yang was a post-doctoral fellow at The Howard Hughes Medical Institute in Chemical Biology with Dr. Stuart Schreiber at Harvard University. Dr. Yang received his Ph.D. in Biochemistry and Molecular Genetics from the University of Texas Southwestern Medical Center while conducting cutting-edge research on cholesterol transcription regulation with Nobel Laureates Drs. Michael Brown and Joseph Goldstein. Dr. Yang received his M.S. in Medicine from Nanjing Medical University, and his M.D. from Hubei Medical College, Xianning.




							Timothy Chen


					
							Mr. Timothy Y. Chen is Director of the Company. He has served as the Corporate Vice President of Hon Hai Technology Group and President of Asia Pacific Telecom since January 2016. He was the President of Telstra International Group from November 2012 to December 2015. He has also served as Chairman of the board of Autohome Inc. since 2012. Previously, Mr. Chen was a partner of a China Opportunities Fund within GL Capital Group from 2010 to 2012. He was the CEO of National Basketball Association China from 2007 to 2010, the Corporate Vice President of Microsoft and the CEO of its Greater China region from 2003 to 2007, the Corporate Vice President of Motorola and the Chairman and President of Motorola (China) Electronics from 2001 to 2003. Before Microsoft, he was the CEO of 21CN Cybernet, a company listed on the Hong Kong Stock Exchange, from 2000 to 2001. Prior to 2000, Mr. Chen spent eight years in China with Motorola, including serving as the General Manager responsible for the sales and marketing for the Greater China Cellular Infrastructure Division. He also spent nine years with AT&T Bell Laboratories in the United States. Mr. Chen holds an MBA degree from the University of Chicago, a master’s degree in both computer science and mathematics from Ohio State University, and a bachelor’s degree from Chiao Tung University.




							Donald Glazer


					
							Mr. Donald W. Glazer is Director odf the company. since February 2013. Mr. Glazer has served as a member of the Board of Trustees of GMO Trust, a mutual fund group, since 2000 and as the Chairman of the Board since 2005. Mr. Glazer was a Co-Founder and Secretary, and from 2002 until 2010, Vice Chairman, of Provant, Inc., a provider of performance improvement training solutions. From 1992 to 1995 Mr. Glazer was President of Mugar/Glazer Holdings and from 1992 to 1993 served as Vice Chairman—Finance of New England Television Corp and WHDH-TV, Inc. From 1997 to the present, Mr. Glazer has served as Advisory Counsel to Goodwin Procter LLP. From 1970 to 1997, Mr. Glazer worked at Ropes & Gray LLP, from 1978 as a Partner. At Ropes & Gray, Mr. Glazer chaired the firm's Emerging Companies Group. Mr. Glazer was also a Lecturer in Law at Harvard Law School from 1978 to 1991, teaching a course called The Business Lawyer. Mr. Glazer is a former member of the boards of directors of Environics Inc.; Kronos Incorporated; Reflective Technologies, Inc.; and Teleco Oilfield Services Inc. Mr. Glazer received his A.B. from Dartmouth College; J.D. from Harvard Law School, where he was an editor of the Harvard Law Review; and L.L.M. from the University of Pennsylvania Law School. Additionally, Mr. Glazer is a co-author of both Glazer and FitzGibbon on Legal Opinions, Third Edition (Aspen Publishers) and Massachusetts Corporation Law & Practice, Second Edition (Aspen Publishers). Mr. Glazer's qualifications to sit on our board of directors include his extensive leadership, executive, managerial, business, and corporate legal experience.




							Michael Goller


					
							Mr. Michael J. Goller is Director of the company. since April 2015. Mr. Goller has been with Baker Bros. Advisors LP since 2005 and currently serves as a Managing Director. Prior to joining Baker Bros., Mr. Goller served as an Associate of JPMorgan Partners, LLC where he focused on venture investments in the life sciences sector from 1999 to 2003. Mr. Goller began his career as an investment banker with Merrill Lynch and Co. from 1997 to 1999. Mr. Goller holds a B.S. in Molecular and Cell Biology from The Pennsylvania State University and Masters degrees in each of Biotechnology (School of Engineered and Applied Sciences) and Business Administration (Wharton School) from the University of Pennsylvania. We believe that Mr. Goller is qualified to serve on our board of directors based on his experience in the life sciences industry and for his knowledge in financial and corporate development matters.




							Ranjeev Krishana


					
							Mr. Ranjeev Krishana is Director of the company. since October 2014. Mr. Krishana has worked at Baker Bros. Advisors LP from 2011 to the present and currently serves as Head of International Investments. Prior to joining Baker Bros., Mr. Krishana held a series of commercial, strategy, and business development leadership roles for Pfizer, Inc.'s pharmaceutical business across a variety of international regions and markets, including Asia, Eastern Europe, and Latin America. Mr. Krishana was at Pfizer from 2003 to 2007 and from 2008 to 2011. From 2008 to 2010, Mr. Krishana was based in Beijing, China, where he served as a Senior Director and a member of the Pfizer China Leadership Team. Mr. Krishana began his career as a strategy consultant at Accenture plc. Mr. Krishana holds a B.A. in Economics and Political Science from Brown University, and a Masters of Public Policy from Harvard University.




							Xiaodong Wang


					
							Dr. Xiaodong Wang, Ph.D. is Director of the Company. He was Director Nominee of the company. Dr. Wang has served as the founding Director of the National Institute of Biological Sciences in Beijing since 2003 and became its Director and Investigator in 2010. Previously, he was a Howard Hughes Medical Institute Investigator from 1997 to 2010 and held the position of the George L. MacGregor Distinguished Chair Professor in Biomedical Sciences at the University of Texas Southwestern Medical Center in Dallas, Texas from 2001 to 2010. In 2004, Dr. Wang founded Joyant Pharmaceuticals, Inc., a venture capital-backed biotechnology company focused on the development of small molecule therapeutics for cancer. Dr. Wang received his Ph.D. in Biochemistry from the University of Texas Southwestern Medical Center and B.S. in Biology from Beijing Normal University. Dr. Wang has been a member of the National Academy of Science, USA since 2004 and a foreign associate of the Chinese Academy of Sciences since 2013.




							Qingqing Yi


					
							Mr. Qingqing Yi is Director of the company. since October 2014. Mr. Yi is a Principal at Hillhouse Capital Group, or Hillhouse. He has worked with Hillhouse since the inception of the firm in 2005. Prior to joining Hillhouse, Mr. Yi was an Equity Research Analyst at China International Capital Corporation. Mr. Yi's work at Hillhouse includes investments in the healthcare and consumer sectors in both its public and private equity portfolios. He received a B.S in Engineering from Shanghai Maritime University, as well as an MBA from University of Southern California.











					Basic Compensation





Name
Fiscal Year Total




							John Oyler

1,383,490




							Howard Liang

--




							Wendy Yan

91,978




							Jason Yang

147,230




							Timothy Chen

--




							Donald Glazer

--




							Michael Goller

--




							Ranjeev Krishana

--




							Xiaodong Wang

--




							Qingqing Yi

--



As Of 
30 Dec 2014





					Options Compensation





Name
Options
Value




							John Oyler

0
0




							Howard Liang

0
0




							Wendy Yan

0
0




							Jason Yang

0
0




							Timothy Chen

0
0




							Donald Glazer

0
0




							Michael Goller

0
0




							Ranjeev Krishana

0
0




							Xiaodong Wang

0
0




							Qingqing Yi

0
0









					Insider Trading












Name
Shares Traded
Price


Wang (Xiaodong)
799
$73.22


Wang (Xiaodong)
15,501
$72.58


Wang (Xiaodong)
3,700
$71.67


Glazer Donald W
7,206
$72.36


Glazer Donald W
3,604
$71.71


Oyler (John V)
3,071
$67.36


Oyler (John V)
51,821
$66.35


Oyler (John V)
10,324
$62.57


Oyler (John V)
44,695
$64.51


Oyler (John V)
6,901
$61.50


Oyler (John V)
7,345
$60.62


Oyler (John V)
64,553
$65.42


Oyler (John V)
300
$68.11


Oyler (John V)
30,390
$63.63


Wang (Xiaodong)
6,600
$45.53


Wang (Xiaodong)
28,400
$44.82


Oyler (John V)
4,500
$45.73


Oyler (John V)
10,981
$44.62


Oyler (John V)
24,414
$43.85


Oyler (John V)
56,805
$44.06


Oyler (John V)
1,800
$44.78


Wang (Xiaodong)
5,539
$40.00


Wang (Xiaodong)
4,491
$41.01


Wang (Xiaodong)
9,970
$40.71


Oyler (John V)
2,100
$42.02




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research






















JOHN OYLER - ELIZABETHTOWN, PA - Company Information









 



























Products
Resources
My Account












Talk to a D&B Advisor 
1-800-280-0780 




Business Directory



PA



ELIZABETHTOWN



Nonclassifiable Establishments



Nonclassifiable Establishments



                            JOHN OYLER
                                    



 





















J 


JOHN OYLER
CLAIM THIS BUSINESS



421 ROCKWOOD DR ELIZABETHTOWN, PA 17022
Get Directions



(717) 367-2192





Business Info



 Founded 2010
 Incorporated 
 Annual Revenue --
 Employee Count 0
 Industries Nonclassifiable Establishments
 Contacts JOHN OYLER







Contact Business







Your Email Address

Subject:


Message


Send Message





Company Summary


John Oyler is located at 421 Rockwood Dr in Elizabethtown and has been in the business of Nonclassifiable Establishments since 2010. 









VERIFIED Status:
UNVERIFIED



Address:
UNVERIFIED





LAST VERIFIED:

                                    --
                                



Phone:

                                    UNVERIFIED
                                





Payment Method:
UNVERIFIED


view full report





Similar Businesses Nearby


                                        Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Competitive Landscape


                                        Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Payments Accepted

NO DATA



Hours



                                        Sunday 

                                        

                                                                                            --
                                            
                                        



                                        Monday 

                                        

                                                                                            --
                                            
                                        



                                        Tuesday 

                                        

                                                                                            --
                                            
                                        



                                        Wednesday 

                                        

                                                                                            --
                                            
                                        



                                        Thursday 

                                        

                                                                                            --
                                            
                                        



                                        Friday 

                                        

                                                                                            --
                                            
                                        



                                        Saturday 

                                        

                                                                                            --
                                            
                                        







J

VIEW ADDITIONAL DATA                        
Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it. 







Credibility Review





Google





Facebook.com





Yellowbook.com





Bing.com





Yellowpages.com





MerchantCircle





Tele Atlas (TomTom)





Twitter.com





AOL





MapQuest





Yahoo Local





Apple/Siri





Groupon





Hotfrog.com





Comcast.net Search





ReachLocal





Admedia





Dealsplus





Shoptopia.com





Alteryx





Dogtime Media





KSL.com





Sirtune





AmericanTowns.com





Driverside





Kudzu.com





SpecialsAgent.com





Answers.com





eGood





LawInfo.com





spotlikes.com





anywho.com





eGumball





Likeness.com





Spotzot





eServiceLog





MapMyRun





TechnoCom





apartmentguide.com





ezlocal.com





EZToUse.com





Teleroute





AroundMe.com





metropolist.com





Therapists.com





Atlanta NewHomes





FindLaw.com





Time Out New York





Avantar





FindTheBest.com





mojopages.com





B2B Yellowpages





Fivestar Software





MyCityWay.com





TripAdvisor





bckyrd.com





GiftCards.com





MyCoupons.com





beachcalifornia.com





GoLocal247.com





mymove.com





UpMeSocial.com





Belo





GoodInfo





News-Gazette





Nokia





usdirectory.com





Cars.com





Nomao





Centzy.com





hibu





Openlist.com





ChaCha Search





Homeplate.com





OwnLocal.com





VisiKard





challama.com





Homestore





patch.com





Voltari





CityBot





Pelopidas





Vouchd





ClassifiedAds





Hostway





PlaceIQ





WalkScore.com





CloudMade





Hoodoyou





PlanetDiscover.com





WeddingWire.com





PowerProfiles





Where Inc.





Contractors.com





iGoLocal.com





Radiate Media





Wikiocity





CouponMap





Indeed.com





Wimgo.com





CrowdSpot





Innova Electronics





Intellistrand





realtor.com





DataSphere





InTheMO.com





Reply.com





Yellowbot.com





JiWire





Rocket Fuel





YellowPageCity.com





DMV.org





Justclicklocal.com





Dirxion





Keen.com





Zidster.com












Photos














































Business Credit Report
Receive a one-time comprehensive credit report on this company.
get full credit report


Facebook








Twitter








Yelp






































Call 1.800.280.0780 to speak with a D&B Advisor Today!







Customer Resources
Products
Education Center
Business Articles & Insights
Glossary
Contact Us
Customer Support
Communication Preferences
Search for D&B D-U-N-S




Our Company
About Us
Company History
Business Credit History
Careers
Press Releases
News
Success Stories
Hoovers




Our Network
Partners
Affiliates
Blog
Access to Capital
Entrepreneurial Initiative
D&B International
SupplierEdge




Site Links
Business Directory
Site Map
PIPEDA
Privacy Policy
Website Terms of Service
Product License Agreement







© Dun & Bradstreet, Inc. 2017. All rights reserved.


















BeiGene | Executive Management - BeiGene
















































































Patients

Pipeline
Clinical Trials


Media

Press Releases
Email Alerts


Contact
 










中文English 
















中文English 







Company

About Us
Our Vision
Management Team

Executive Management
Research
Development
Process Development & Manufacturing
Commercial & Operations


Board of Directors
Scientific Advisory Board
Contact


Our Science

Cancer Biology Platform
Molecularly Targeted Agents
Immuno-oncology Therapies
Combination Solutions


Pipeline

Clinical Candidates

Overview
BGB-3111
BGB-A317
BGB-290
BGB-283


Preclinical Candidates


Business Development

Overview


Investors

Investors Overview
Stock Information

Stock Quote
Stock Chart
Historical Price Lookup
Investment Calculator


Financial Information

SEC Filings
Annual Reports


News & Events

Press Releases
Events Calendar


Corporate Governance

Documents & Charters


Investor Services

Information Request
Email Alerts
IR Contact


Investor FAQ


Careers

Our Culture
Job Opportunities
Campus Recruiting


Patients

Pipeline
Clinical Trials


Media

Press Releases
Email Alerts


Contact

 





ManagementTeam








Executive Management

Xiaodong Wang, Ph.D.Founder & Chairman of Scientific Advisory Board
Founded BeiGene in 2010, and has served as Chairman of Scientific Advisory Board since 2011
Founding Director & Architect of 700-person team at the National Institute of Biological Sciences (NIBS) in Beijing (2003-present)
Howard Hughes Medical Institute Investigator, George L. MacGregor Distinguished Chair in Biomedical Sciences (1997-2010) and Professor in Biomedical Sciences (2001-2010) at University of Texas Southwestern Medical Center
Member of National Academy of Sciences, USA
Foreign associate of Chinese Academy of Sciences
Founder of Joyant Pharmaceuticals, venture capital-backed oncology biotech in US
Ph.D. in Biochemistry from University of Texas Southwestern Medical Center
B.S. in Biology from Beijing Normal University

John V. OylerFounder & CEO
Has served as CEO and Director since founding BeiGene in 2010
Founder & CEO of BioDuro, 700-person integrated research CRO in Beijing, sold to Pharmaceutical Product Development Inc. with attractive returns (2005-2009)
CEO of Galenea, Boston biotech started from MIT with funding from Otsuka, (2002-2004)
Founder, President of Telephia, sold to Nielsen (1997-2002)
Co-CEO of Genta (GNTA), publicly-traded oncology company that grew in late ’90s to $1.7 billion in revenues (1997-1998)
Began career at McKinsey & Company
MBA from Stanford University
B.S. from Massachusetts Institute of Technology

Howard Liang, Ph.D.CFO and Chief Strategy Officer
Former Managing Director and Head of Biotechnology Equity Research at Leerink Partners
Institutional Investor All-America Research Team, Biotechnology / Mid- & Small-Cap, 2015; Bloomberg Markets Top US Analysts in Biotechnology, 2012; Wall Street Journal “Best of the Street” in Biotechnology and Pharmaceuticals, 2010 and in Biotechnology, 2008
Senior biotechnology analyst at AG Edwards, JMP Securities; Associate Analyst at Prudential Securities covering major and specialty pharmaceuticals
Senior Scientist at Abbott Laboratories and member of industry’s leading structure-based drug design teams; authored review and 13 papers including six in Nature, Science, and Proceedings of National Academy of Sciences
M.B.A., and Ph.D. in Biochemistry and Molecular Biology from The University of Chicago
B.S. in Chemistry from Peking University

Amy Peterson, M.DChief Medical Officer, Immuno-oncology
Former Vice President of Clinical Development at Medivation
Former Associate Group Medical Director at Genentech
Former Instructor of Medicine in Oncology at the University of Chicago
Former residency in Internal Medicine at Northwestern Memorial Hospital and Fellowship in Hematology and Oncology at the University of Chicago
M.D. from Thomas Jefferson University in Philadelphia, PA
Bachelor of Arts from Wesleyan University in Middletown, CT

Jane Huang, M.D.Chief Medical Officer, Hematology
Former Vice President and Head of Clinical Development at Acerta Pharma (a subsidiary of Astra Zeneca)
Former Group Medical Director, Product Development-Oncology at Genentech (a Member of the Roche Group)
Adjunct Clinical Faculty and Attending in Thoracic Oncology at Stanford University
Board Certified in Hematology, Oncology, and Internal Medicine
Fellowship in Hematology and Oncology and Residency in Internal Medicine at Stanford University
M.D. from University of Washington School of Medicine
Bachelor of Science degree with Honors in Biological Sciences from Stanford University

Eric Hedrick, M.D.Chief Advisor
Former Chief Medical Officer at Epizyme
VP of Oncology Development at Pharmacyclics
Group Medical Director at Genentech
Attending Physician in Hematology Service at Memorial Sloan-Kettering Cancer Center
M.D. from University of Maryland School of Medicine

Ji Li, Ph.D.Global Head of Business Development
More than 18 years of Business Development and R&D experience in biopharma industry


Former member of the Board of Directors of BeiGene, as a representative for Merck, up until BeiGene’s IPO in February 2016


Former Vice President of Business Development and Licensing at Merck & Co. Inc


Former Executive Licensing Director, External R&D at Amgen


Key member of Amgen research team discovered and validated the RANKL signaling pathway that has led to the development of Denosumab, the current standard of care therapy for osteoporosis, cancer bone metastasis and other bone loss indications.


Ph.D. in Neuroscience from Mount Sinai School of Medicine in New York


B.S. in Pharmacology from Shanghai Medical University


 

 



Company 
CompanyAbout Us
Our Vision
Management Team

Executive Management
Research
Development
Process Development & Manufacturing
Commercial & Operations


Board of Directors
Scientific Advisory Board
Contact
 

 


 



























